drugset / Trial / NCT06255964
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The efficacy and safety of IAP0971 single drug or combined with BCG intravesical instillation in the treatment of high-risk non muscle invasive bladder cancer with BCG treatment failure.
Timeline
- Start
- 2024-02-15
- Primary completion
- 2024-10-07
- Completion
- 2026-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IAP0971 | Unknown | — | Other |
| Background | Bacillus Calmette Guerin | Unknown | — | Other |